Joule Financial LLC reduced its position in shares of Paysign, Inc. (NASDAQ:PAYS – Free Report) by 0.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 400,969 shares of the company’s stock after selling 3,050 shares during the period. Paysign comprises about 0.9% of Joule Financial LLC’s investment portfolio, making the stock its 19th largest holding. Joule Financial LLC owned 0.74% of Paysign worth $2,887,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of PAYS. Strs Ohio acquired a new position in Paysign during the 1st quarter worth approximately $259,000. Two Sigma Investments LP lifted its position in shares of Paysign by 98.8% in the fourth quarter. Two Sigma Investments LP now owns 181,775 shares of the company’s stock worth $549,000 after purchasing an additional 90,346 shares in the last quarter. GSA Capital Partners LLP boosted its holdings in Paysign by 38.3% during the first quarter. GSA Capital Partners LLP now owns 271,781 shares of the company’s stock worth $576,000 after purchasing an additional 75,311 shares during the last quarter. Brendel Financial Advisors LLC bought a new position in Paysign in the second quarter valued at $338,000. Finally, Nuveen LLC acquired a new stake in Paysign in the 1st quarter valued at $95,000. Institutional investors and hedge funds own 25.89% of the company’s stock.
Paysign Price Performance
Shares of NASDAQ:PAYS opened at $6.34 on Monday. The business’s 50 day simple moving average is $5.79 and its 200 day simple moving average is $4.85. Paysign, Inc. has a 1 year low of $1.80 and a 1 year high of $8.88. The company has a market capitalization of $345.21 million, a P/E ratio of 52.83 and a beta of 0.93.
Insider Activity
In other news, insider Robert Strobo sold 26,521 shares of the company’s stock in a transaction that occurred on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $188,033.89. Following the completion of the sale, the insider owned 247,290 shares of the company’s stock, valued at approximately $1,753,286.10. This represents a 9.69% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CFO Jeffery Bradford Baker sold 30,396 shares of Paysign stock in a transaction that occurred on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $215,507.64. Following the completion of the transaction, the chief financial officer directly owned 252,273 shares in the company, valued at $1,788,615.57. This trade represents a 10.75% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 159,602 shares of company stock valued at $1,131,578. Company insiders own 22.40% of the company’s stock.
Analysts Set New Price Targets
A number of research firms have recently commented on PAYS. Lake Street Capital increased their price objective on shares of Paysign from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. DA Davidson set a $9.00 price target on Paysign in a research report on Thursday, August 7th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Paysign in a research report on Saturday, September 27th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $8.56.
View Our Latest Analysis on Paysign
About Paysign
Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.
Featured Stories
- Five stocks we like better than Paysign
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 Defense Stocks Surging as Ukraine Tensions Deepen
- Investing in Commodities: What Are They? How to Invest in Them
- Starbucks Stock Slumps; This Competitor Shows Strength
- How to Use the MarketBeat Excel Dividend Calculator
- The Trade Desk: 2 Signs of a Comeback, 1 Risk Ahead
Receive News & Ratings for Paysign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paysign and related companies with MarketBeat.com's FREE daily email newsletter.